Rocket Pharmaceuticals
RCKT
RCKT
92 hedge funds and large institutions have $555M invested in Rocket Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 20 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less call options, than puts
Call options by funds: $340K | Put options by funds: $425K
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
25% less capital invested
Capital invested by funds: $736M → $555M (-$181M)
Holders
92
Holding in Top 10
2
Calls
$340K
Puts
$425K
Top Buyers
| 1 | +$16.4M | |
| 2 | +$7.42M | |
| 3 | +$4.9M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.08M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.84M |
Top Sellers
| 1 | -$32.4M | |
| 2 | -$18.7M | |
| 3 | -$11.8M | |
| 4 |
Millennium Management
New York
|
-$6.2M |
| 5 |
AG
Artal Group
Luxembourg
|
-$5.4M |